Rotigotine
Brand name: Neupro
Rank #372 of 500 drugs by total cost
$26.2M
Total Cost
23,665
Total Claims
$26.2M
Total Cost
1,020
Prescribers
$1,106
Cost per Claim
1,463
Beneficiaries
31,325
30-Day Fills
$26K
Avg Cost/Provider
23
Avg Claims/Provider
About Rotigotine
Rotigotine (sold as Neupro) was prescribed 23,665 times by 1,020 Medicare Part D providers in 2023, costing the program $26.2M. At $1,106 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 369 | Glycerol Phenylbutyrate (Ravicti) | $26.6M | 268 |
| 370 | Doravirine (Pifeltro) | $26.4M | 14,437 |
| 371 | Brinzolamide/Brimonidine Tart (Simbrinza) | $26.3M | 97,240 |
| 372 | Rotigotine (Neupro) | $26.2M | 23,665 |
| 373 | Chlorpromazine Hcl (Chlorpromazine Hcl) | $25.9M | 78,710 |
| 374 | Perampanel (Fycompa) | $25.9M | 20,876 |
| 375 | Timolol Maleate (Timolol Maleate) | $25.8M | 1,129,537 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology